Found: 9
Select item for more details and to access through your institution.
Boron neutron capture therapy of cancer: where do we stand now?
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 889, doi. 10.1002/cac2.12581
- By:
- Publication type:
- Article
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 915, doi. 10.1002/cac2.12590
- By:
- Publication type:
- Article
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 884, doi. 10.1002/cac2.12589
- By:
- Publication type:
- Article
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 879, doi. 10.1002/cac2.12588
- By:
- Publication type:
- Article
SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 910, doi. 10.1002/cac2.12586
- By:
- Publication type:
- Article
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 921, doi. 10.1002/cac2.12585
- By:
- Publication type:
- Article
Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 855, doi. 10.1002/cac2.12583
- By:
- Publication type:
- Article
Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 893, doi. 10.1002/cac2.12582
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 853, doi. 10.1002/cac2.12437
- Publication type:
- Article